跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,801 条关于
“ES2B-I002”
全部
1,801
临床试验
636
药物
1,053
机构
0
资讯
112
去年
ExpreS2ion Biotech Advances to Clinical Phase with HER2 Breast Cancer Vaccine, Reports Strong Q4 2024 Progress
去年
ExpreS2ion's ES2B-C001 HER2-Targeting Vaccine Approved for Phase I Trial in Breast Cancer
去年
ExpreS2ion Amends Clinical Trial Protocol to Test Breast Cancer Vaccine in Combination with Antibody-Drug Conjugates
7个月前
ExpreS2ion Biotech Reports Promising Immune Response Data from HER2-Targeting Cancer Vaccine Phase I Trial
17天前
Veeva Falcon Safety Automates Adverse Event Intake Across E2B-Compliant Systems
2年前
Capricor Therapeutics Gains FDA Alignment on HOPE-3 Trial Design for CAP-1002 in Duchenne Muscular Dystrophy
去年
Pierre Fabre's PFL-002/VERT-002 Enters Phase I/II Trial for NSCLC with MET Alterations
去年
Pierre Fabre's PFL-002/VERT-002 Enters Phase I/II Trial for NSCLC with MET Alterations
2年前
Boryung Pharmaceutical's BR-6002 Advances in Cardiovascular Disease Treatment
去年
NTLA-2002 Gene Editing Shows Promise in Hereditary Angioedema
第 1 页,共 12 页
上一页
下一页